SEC Filing Summary: Nephros, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Nephros, Inc. on April 26, 2005, covering events occurring on the same date. The filing primarily addresses corporate governance updates rather than operational or financial performance.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to the announcement of a board appointment and does not contain financial statements or operational data.
Material Changes
The material change reported is the appointment of Bernard Salick, M.D., as a new director to the Company's Board of Directors, announced via a press release on April 26, 2005.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, risks, contingencies, or unusual items. The document serves solely to disclose the board appointment.
Key Facts for Investor Verification
- Confirmation of Bernard Salick, M.D.'s appointment to the Board of Directors.
- Review of the attached press release (Exhibit 99.1) for details on the director's background and qualifications.
- Verification that no other material events were omitted from this specific 8-K filing.